Blackhawk Growth Corp is a publicly listed investment issuer on the Canadian Securities Exchange, headquartered in Vancouver, Canada. Incorporated in 1986 and formerly known as Blackhawk Resource Corp, it functions as a publicly owned investment manager that acquires and invests in high-potential assets, technologies, and projects across North America and Europe. The company primarily targets public equity and fixed income markets, with a strategic emphasis on technology and life sciences sectors, including medical technologies, pharmaceuticals, digital health, software, big data, AI, cannabis, and CBD industries. Notable for its innovative model, Blackhawk leverages its investment issuer status to fund research and development, commercialize opportunities, and execute spin-outs or listings, as demonstrated by its successful development and public listing of MindBio, a biopharma company focused on microdosing treatments for mental health. Led by CEO Justin Hanka and CFO John Dinan, Blackhawk Growth Corp positions itself to capitalize on emerging trends, fostering scalable solutions that enhance health and human wellbeing while generating shareholder value through mergers, acquisitions, and divestments in diversified financials.